Lincoln Pharmaceuticals Ltd — Glibenclamide Exporter Profile
Indian Pharmaceutical Exporter · #6 for Glibenclamide · $124.9K export value · DGFT Verified
Lincoln Pharmaceuticals Ltd is the #6 Indian exporter of Glibenclamide with $124.9K in export value and 16 verified shipments. Lincoln Pharmaceuticals Ltd holds a 0.3% market share in Glibenclamide exports across 5 countries.
Lincoln Pharmaceuticals Ltd — Glibenclamide Export Profile: Buyers & Destinations
Where Does Lincoln Pharmaceuticals Ltd Export Glibenclamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $71.2K | 6 | 47.6% |
| ZAMBIA | $60.0K | 6 | 40.1% |
| BOLIVIA | $12.0K | 1 | 8.0% |
| MYANMAR | $3.3K | 1 | 2.2% |
| FIJI | $3.2K | 5 | 2.2% |
Lincoln Pharmaceuticals Ltd exports Glibenclamide to 5 countries. The largest destination is TANZANIA accounting for 47.6% of Lincoln Pharmaceuticals Ltd's Glibenclamide shipments, followed by ZAMBIA (40.1%) and BOLIVIA (8.0%). These destinations reflect Lincoln Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Glibenclamide from Lincoln Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HEKO PHARMACY LTD | TANZANIA | $54.1K | 4 |
| Y P L | ZAMBIA | $24.8K | 1 |
| YASH PHARMACEUTICALS LTD. | ZAMBIA | $19.6K | 3 |
| HEKO PHARMACY LIMITED | TANZANIA | $17.1K | 2 |
| FARMEDICAL S.R.L. | BOLIVIA | $12.0K | 1 |
| YASH PHARMACEUTICALS LTD | ZAMBIA | $10.4K | 1 |
| YASH PHARMACEUTICAL LTD. | ZAMBIA | $5.2K | 1 |
| WIN HTUN GARMENT TRADING LTD | MYANMAR | $3.3K | 1 |
| MAKANS LIMITED | FIJI | $2.7K | 4 |
| MAKANS PTE LTD. | FIJI | $570 | 1 |
Lincoln Pharmaceuticals Ltd supplies Glibenclamide to 10 buyers globally. The largest buyer is HEKO PHARMACY LTD (TANZANIA), followed by Y P L (ZAMBIA) and YASH PHARMACEUTICALS LTD. (ZAMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Glibenclamide Export Value and How Much Does Lincoln Pharmaceuticals Ltd Contribute?
India exported $2.1M worth of Glibenclamide through 930 shipments from 194 suppliers to 100 countries, serving 335 buyers globally. Lincoln Pharmaceuticals Ltd contributes $124.9K to this total, accounting for 0.3% of India's Glibenclamide exports. Lincoln Pharmaceuticals Ltd ships Glibenclamide to 5 countries through 10 buyers.
What Is the Average Shipment Value for Lincoln Pharmaceuticals Ltd's Glibenclamide Exports?
Lincoln Pharmaceuticals Ltd's average Glibenclamide shipment value is $7.8K per consignment, based on 16 shipments totaling $124.9K. The largest destination is TANZANIA (47.6% of Lincoln Pharmaceuticals Ltd's Glibenclamide exports).
How Does Lincoln Pharmaceuticals Ltd Compare to Other Indian Glibenclamide Exporters?
Lincoln Pharmaceuticals Ltd ranks #6 among 194 Indian Glibenclamide exporters with a 0.3% market share. The top 3 exporters are MEDOPHARM ($420.3K), M. J. BIOPHARM PRIVATE LIMITED ($375.5K), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($274.9K). Lincoln Pharmaceuticals Ltd processed 16 shipments to 5 destination countries.
What Glibenclamide Formulations Does Lincoln Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GLIBENCLAMIDE TABLETS BP 5 MG (DIOLIN)(46788X 10X10 TAB) | $24.8K | 1 |
| Glibenclamide Tablet BP 5 mg (Diolin) (4 | $19.9K | 1 |
| GLIBENCLAMIDE TABLETS BP 5 MG (DIOLIN)(37034X10X10 TAB) | $19.6K | 3 |
| Glibenclamide Tablet BP 5 mg (Diolin)(47 | $18.9K | 1 |
| Glibenclamide Tablet BP 5 mg Diolin42 | $16.8K | 1 |
| Glibenclamide And Metformine Tablets (Me | $12.0K | 1 |
| Glibenclamide Tablets BP 5 mg Diolin1960610x10 TabAS PER INV | $10.4K | 1 |
| Glibenclamide Tablet BP 5 mg Diolin 19182X10X10 TAB | $7.7K | 1 |
| Glibenclamide Tablet BP 5 mg (Diolin)(19 | $7.6K | 1 |
| Glibenclamide Tablets BP 5 mg (Diolin)(9 | $5.2K | 1 |
Lincoln Pharmaceuticals Ltd exports 17 distinct Glibenclamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GLIBENCLAMIDE TABLETS BP 5 MG (DIOLIN)(46788X 10X10 TAB) with 1 shipments worth $24.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Lincoln Pharmaceuticals Ltd Compare to Nearest Glibenclamide Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | CIPLA LIMITED | $235.1K | 27 | 1 | $8.7K |
| 5 | CAPLIN POINT LABORATORIES LIMITED | $169.2K | 17 | 5 | $10.0K |
| 6 | LINCOLN PHARMACEUTICALS LTD ★ | $124.9K | 16 | 5 | $7.8K |
| 7 | ZYDUS LIFESCIENCES LIMITED | $116.0K | 22 | 5 | $5.3K |
| 8 | MEDICAMEN BIOTECH LIMITED | $110.9K | 11 | 8 | $10.1K |
Lincoln Pharmaceuticals Ltd ranks #6 among 194 Indian Glibenclamide exporters. Average shipment value of $7.8K compared to the market average of $11.0K. The closest competitors by value are CIPLA LIMITED and CAPLIN POINT LABORATORIES LIMITED.
Which Indian Ports Ship Glibenclamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 133 | 14.3% |
| NHAVA SHEVA SEA (INNSA1) | 130 | 14.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 99 | 10.6% |
| JNPT/ NHAVA SHEVA SEA | 61 | 6.6% |
| JNPT | 45 | 4.8% |
| Bombay Air | 33 | 3.5% |
| MUNDRA SEA | 32 | 3.4% |
| AHEMDABAD ICD | 27 | 2.9% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Glibenclamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Glibenclamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lincoln Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 19 individual customs records matching Lincoln Pharmaceuticals Ltd exporting Glibenclamide, covering 17 formulations to 5 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 335+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Glibenclamide Export Data from Lincoln Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lincoln Pharmaceuticals Ltd's Glibenclamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lincoln Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Glibenclamide Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lincoln Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Glibenclamide. For current shipment-level data, contact TransData Nexus.